An Open-label, Multi-centre, Long-term Extension Study of Zanubrutinib (BGB-3111) in patients with B-cell Malignancies.

  • Fleming, Shaun Alan, (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date21/01/2021/01/20

Keywords

  • Malignant Haematology
  • B-cell Malignancies
  • Clinical trial